|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Cost of sales | |||||
| Intangible asset impairment | |||||
| Gross profit | |||||
| Selling, general and administrative | |||||
| Research, development and engineering | |||||
| Loss (gain) on sale of fixed assets | |||||
| Operating loss | |||||
| Interest income | |||||
| Interest expense | |||||
| Foreign currency (loss) gain | |||||
| Other | |||||
| Loss before income taxes | |||||
| Income tax provision | |||||
| Net Loss | |||||
| Loss Per Share: | |||||
| Net loss per basic share | |||||
| Net loss per diluted share | |||||
| Weighted average shares outstanding - basic | |||||
| Weighted average shares outstanding - diluted | |||||
Loading...